18,947 results on '"GIANT cell arteritis"'
Search Results
2. Temporal artery ultrasonography for the diagnosis of giant cell arteritis: a case report.
3. Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
4. A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
5. The Applanation Tonometry in GCA Pilot (ATOM-GCA)
6. Optic Nerve Sheath Ultrasound in Giant Cell Arteritis (SONIC-GCA)
7. A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154 (AIM-PMR)
8. Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) (REPLENISH-EXT)
9. Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis (ULTRA)
10. Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR
11. Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) (REPLENISH)
12. Pilot Study Evaluating the Value of Thrombomodulin in Ruling Out the Diagnosis of Giant Cell Arteritis (GCA) in Pseudo Rheumatoid Arthritis (PRA) (THROPIQ) (THROPIQ)
13. Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission (GigAINt)
14. Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)
15. TocilizuMab discontinuAtion in GIant Cell Arteritis (MAGICA)
16. Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis (DOCTA) (DOCTA)
17. Abatacept for the Treatment of Giant Cell Arteritis
18. Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica (RHUMATEP)
19. Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement (TOGIAC)
20. Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica (ITTGPMR)
21. PET Imaging of Giant Cell and Takayasu Arteritis (PITA)
22. MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial (METOGiA)
23. Visual Involvement in Giant Cell Arteritis (Visu-GCA)
24. A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)
25. A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis (THEIA)
26. A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)
27. Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic (GCAIO)
28. Vessel Wall Enhancement in Giant Cell Arteritis (VEGA)
29. One-Time DNA Study for Vasculitis
30. Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim) (EvHortim)
31. Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years.
32. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica.
33. Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc)
34. Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis (GCA-Biom)
35. Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis (MTXinGCA)
36. A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis (CRAFT)
37. Bridging Gaps and Charting Future Directions in Vasculitis.
38. Imaging in Large Vessel Vasculitis—A Narrative Review.
39. Von Willebrand factor: a possible biomarker for disease activity in vasculitis.
40. Nationwide epidemiological survey of polyarteritis nodosa in Japan in 2020.
41. Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey.
42. Evolution and outcomes of aortic dilations in giant cell arteritis.
43. Clinical features, imaging use, and management in giant cell arteritis: a retrospective single-center study.
44. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies.
45. The Explication of Race in Rheumatology Disparities.
46. FDG PET/CT in large vessel vasculitis.
47. 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry.
48. Calciphylaxis Mimicking Giant Cell Arteritis: A Case Report.
49. Epidemiology of large vasculitis in Shanghai, China: A 10‐year multicenter hospital‐based study and systematic review.
50. MRVAS—introducing a standardized magnetic resonance scoring system for assessing the extent of inflammatory burden in giant cell arteritis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.